Stocks Screeners Features Pricing
Sign In Get Started

Bath & Body Works, Inc. Stock Analysis

NYSE: BBWI | Consumer Discretionary | Specialty Retail
Price $20.97 +$0.85 (+4.22%)
P/E Ratio 7.0 TTM
52-Week Range
Low $14 High $32
Market Cap $4.44B USD
ROE Negative equity

Market data as of Aug 3, 2026 · Financials as of Jan 2026

Published May 28, 2026 · Updated Jul 26, 2026

How has Bath & Body Works, Inc. (BBWI) been performing? Here's a data-driven look at its financials, valuation, and shareholder returns.

Bath & Body Works, Inc. Revenue Analysis

Bath & Body Works, Inc. reported revenue of $7.29B in FY2025, largely unchanged from FY2024.

The 6-year revenue CAGR of 5.1% reflects steady, if not spectacular, top-line expansion from $5.41B to $7.29B.

Bath & Body Works, Inc.'s $7.29B revenue base puts it in the mid-cap bracket among US consumer discretionary companies.

With 4 straight years of revenue decline, this isn't a blip, the trajectory is clear for Bath & Body Works, Inc..

Revenue Trend
Year Revenue YoY %
FY2025 $7.29B -0.2%
FY2024 $7.31B -1.6%
FY2023 $7.43B -1.7%
FY2022 $7.56B -4.1%
FY2021 $7.88B +22.5%

Explore the full 10-year revenue trend with interactive charts

Profitability

Bath & Body Works, Inc.'s bottom line weakened to $649.0M in FY2025, a 18.7% decline year-over-year.

The net margin narrowed from 10.9% to 8.9%, suggesting rising cost pressures.

Diluted EPS came in at $3.07 for FY2025, down from $3.61 a year earlier.

Dive into the bottom-line numbers with interactive charts

Dividends & Buybacks

The company returned $0.79 per share to shareholders via dividends in FY2025 (3.97% yield).

Bath & Body Works, Inc.'s 10+ year streak of consecutive dividends speaks to the stability of its cash flows.

At a 25.7% payout ratio, Bath & Body Works, Inc. strikes a reasonable balance between shareholder returns and retained earnings.

Annual Dividend Summary
Year DPS Payout Ratio
FY2025 $0.79 25.7%
FY2024 $0.80 22.2%
FY2023 $0.79 20.8%
FY2022 $0.80 23.3%
FY2021 $0.44 9.0%

On the buyback front, Bath & Body Works, Inc. has spent $5.79B repurchasing shares over 9 years, reducing the float and boosting per-share metrics.

See how buybacks have impacted Bath & Body Works, Inc.'s share count over time

Financial Strength

Bath & Body Works, Inc. Debt & Equity Overview (FY2025)
Metric Value
Cash & Short-term Investments $953.0M
Total Debt $4.09B
Shareholders' Equity -$1.28B
Total Assets $5.07B
Debt-to-Equity Ratio N/A (negative equity)
Current Ratio 1.27x
Interest Coverage 4.1x
Free Cash Flow (TTM) $865.0M

Bath & Body Works, Inc. has negative shareholder equity (equity deficit), a current ratio of 1.27, interest coverage of 4.1x in FY2025, which suggest adequate financial health with manageable leverage.

Bath & Body Works, Inc. shows negative shareholders' equity of $1.28B. While this sounds concerning, it's characteristic of companies that aggressively return capital to shareholders via buybacks, funded by consistent operating cash flows.

Short-term liquidity looks healthy with a current ratio of 1.27x.

A 4.1x interest coverage ratio gives Bath & Body Works, Inc. a moderate cushion above its debt service costs.

Bath & Body Works, Inc. generated $865.0M in free cash flow, providing ample capacity for dividends, buybacks, and debt reduction.

Explore Bath & Body Works, Inc.'s full balance sheet and cash flow analysis below

Bath & Body Works, Inc. employed 60,700 people as of FY2025, about $120.1K in revenue per employee.

See Bath & Body Works, Inc.'s full employee count history and revenue per employee

What Is Bath & Body Works, Inc. Worth?

The big question for investors: is Bath & Body Works, Inc. fairly valued at the current price?

Bath & Body Works, Inc. shares are currently trading at $20.97.

Based on the P/E Ratio model, Bath & Body Works, Inc.'s fair value works out to $28, 23.9% upside from where it trades today.

We also calculate intrinsic value using the DCF and EPS Growth models. Sign up to see the full breakdown with fair value estimates.

Valuation Models
Model Est. Fair Value vs. Current Price
P/E Ratio $28 23.9% upside to fair value
DCF Upgrade Upgrade
EPS Growth Upgrade Upgrade

What Stands Out

In summary, Bath & Body Works, Inc. (BBWI) presents the following picture for fundamental analysts.

Revenue of $7.29B in FY2025, broadly flat versus the prior year.

Long-term revenue has been compounding at 5.1% annually over 6 years.

The company is profitable, with a net margin of 8.9% and net income of $649.0M.

Returned $568.0M to shareholders in FY2025 through dividends and/or buybacks.

Negative shareholders' equity, often a sign of aggressive buyback strategy in companies with strong cash flows.

The P/E Ratio model implies 23.9% upside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.

The detailed charts and valuation models below provide a deeper look at Bath & Body Works, Inc.'s financial trajectory.

Frequently Asked Questions

How much revenue does Bath & Body Works, Inc. generate?
Bath & Body Works, Inc. generated $7.29B in revenue during FY2025.
Is Bath & Body Works, Inc. profitable?
Bath & Body Works, Inc. reported net income of $649.0M in FY2025, with a net margin of 8.9%.
Does Bath & Body Works, Inc. pay a dividend?
Yes, Bath & Body Works, Inc. pays a regular dividend to shareholders.
What is the fair value of Bath & Body Works, Inc. stock?
Based on the P/E ratio model, Bath & Body Works, Inc. appears undervalued, trading at a 28% discount to its estimated fair value of $28.
What industry is Bath & Body Works, Inc. in?
Bath & Body Works, Inc. is in the Specialty Retail industry within the Consumer Discretionary sector.

What does Bath & Body Works, Inc. do?

Bath & Body Works is a specialty retailer of home fragrance, body care, and soaps and sanitizers, sold under the Bath & Body Works and White Barn brands. It operates roughly 1,800 company-owned stores across the US and Canada, complemented by e-commerce and ~340 international partner-operated locations via franchise, license, and wholesale arrangements.

Detailed Charts

Bath & Body Works, Inc. Performance

5-year trend showing revenue, gross profit, and net profit

Bath & Body Works, Inc. sold off part of its business, so FY2019 onward covers only the business it kept. The step at that point is the sale, not a decline.

FY2021 – FY2025

Bath & Body Works, Inc.'s revenue declined 0.2% to $7.29B in FY2025, with net profit also falling 18.7% to $649.00M.

Understanding Company Performance

Revenue is Bath & Body Works, Inc.'s total income from operations. Gross Profit is revenue minus cost of goods sold — the higher it is relative to revenue, the stronger the company's pricing power. Net Profit is the bottom line after all expenses, taxes, and interest. Consistent growth across all three signals a healthy, expanding business. Compare with peers in the same sector.

Is Bath & Body Works, Inc. Profitable?

5-year trend showing gross, operating, and net profit margins

Bath & Body Works, Inc. sold off part of its business, so FY2019 onward covers only the business it kept. The step at that point is the sale, not a decline.

FY2021 – FY2025

Bath & Body Works, Inc.'s net profit margin of 8.9% in FY2025 reflects thin profitability, with operating margin at 15.4% and gross margin at 43.7%.

Understanding Profitability Margins

Gross Profit Margin (GPM) shows what percentage of Bath & Body Works, Inc.'s revenue remains after direct production costs. Operating Profit Margin (OPM) factors in operating expenses like R&D and SG&A. Net Profit Margin (NPM) is the final profitability after all costs including interest and taxes. Stable or improving margins indicate pricing power and cost discipline.

Bath & Body Works, Inc. Revenue & Earnings Growth

5-year trend showing revenue and diluted EPS

Bath & Body Works, Inc. sold off part of its business, so FY2019 onward covers only the business it kept. The step at that point is the sale, not a decline.

FY2021 – FY2025

Bath & Body Works, Inc.'s revenue declined 0.2% and EPS declined 15.0% YoY in FY2025, indicating broad-based weakness.

Understanding Revenue & Earnings Growth

Revenue is Bath & Body Works, Inc.'s total income from operations — the top line. Diluted EPS (Earnings Per Share) is net income divided by all shares that could exist if stock options, RSUs, and convertibles were exercised. Revenue shows how fast the business is growing; EPS shows how much of that growth reaches shareholders after all costs and dilution. Healthy companies tend to grow both in tandem; when revenue grows but EPS shrinks, margins are compressing. Use our stock screener to compare growth profiles across companies.

Bath & Body Works, Inc. Compound Annual Growth Rate (CAGR)

Metric 1-Year 5-Year 10-Year
Revenue -0.2% +2.5% N/A
Net Income -18.7% -5.1% N/A
EPS -15.0% +0.5% N/A
Share Price -23.4% -18.8% -6.9%

Bath & Body Works, Inc.'s 5-year revenue CAGR of 2.5% reflects slow growth, though EPS CAGR of 0.5% trails revenue, suggesting rising costs eating into profits. The share price has declined at -18.8% annually over a comparable period, lagging behind fundamentals — potentially signalling undervaluation.

Bath & Body Works, Inc. Quarterly Performance

Quarterly revenue and net income with a weekly share-price overlay

Upgrade to see the full 5 years (20 quarters) of quarterly data.

FY2025

How to Read Quarterly Performance

Quarterly revenue and net income are Bath & Body Works, Inc.'s most recent three-month results. Each bar shows net income nested inside revenue, since profit is the slice of revenue left after all costs; the taller the green portion relative to the blue, the more of each sales dollar reached the bottom line. A bar below zero is a quarterly loss.

For a long-term view, compare each quarter with the same quarter a year earlier (year-over-year), not with the previous quarter — sequential change is mostly seasonality (for many businesses the holiday quarter is always the biggest). Then watch the trend across several years: is year-over-year revenue growth accelerating or fading; is net income growing at least as fast as revenue (expanding vs compressing margins)? One quarter is noise — the multi-quarter trend is the signal.

Bath & Body Works, Inc. Share Price vs Book Value

Bath & Body Works, Inc. (BBWI) share price vs book value per share — FY2016 – FY2025

Understanding Share Price vs Book Value

Share Price is what the market pays per share of Bath & Body Works, Inc.. Book Value per Share (BVPS) is the company's net equity divided by diluted shares — the accounting floor if the company were liquidated today. When price tracks close to book value the market sees the company as a steady asset; when price runs far above book the market is paying up for expected future earnings. For banks, book value is the primary valuation anchor; for most other companies it's one signal among many.

Unlock Valuation Analysis

Get fair value estimates from multiple valuation models and see whether a stock is undervalued or overvalued.

  • Multi-model fair value estimates (P/E, DCF, EPS Growth)
  • Undervalued/overvalued assessment with upside potential
  • Compare fair values across methodologies

Bath & Body Works, Inc. Free Cash Flow

5-year trend — cash generated after reinvestment

FY2021 – FY2025

Bath & Body Works, Inc.'s free cash flow of $865.00M in FY2025 represents a 11.9% FCF margin — healthy cash generation supporting dividends, buybacks, or debt reduction.

Understanding Free Cash Flow

Free Cash Flow (FCF) is Bath & Body Works, Inc.'s operating cash flow minus capital expenditure — the cash left over after maintaining and growing the business. Unlike net profit, FCF strips out non-cash items (depreciation, stock-based compensation) and includes actual cash spent on assets. Positive FCF means the company can pay dividends, buy back shares, reduce debt, or make acquisitions without raising capital. Consistently negative FCF signals the company is burning cash and may need external funding.

Bath & Body Works, Inc. Financial Ratios

Balance sheet strength and debt servicing capacity

FY2021 – FY2025

Debt-to-Equity

N/A

Negative equity

Current Ratio

1.27

▼ from 1.48

Interest Coverage

4.1x

→ stable

Bath & Body Works, Inc. has negative shareholder equity (equity deficit), a current ratio of 1.27, interest coverage of 4.1x in FY2025, which suggest adequate financial health with manageable leverage.

Understanding Financial Health

Debt-to-Equity (D/E) measures how much debt the company carries relative to shareholder equity — lower means less leverage risk. Current Ratio divides current assets by current liabilities — above 1.0 means the company can cover short-term obligations. Interest Coverage is operating income divided by interest expense — higher means the company earns well above its debt payments. Together these three metrics reveal whether a company can weather downturns without financial distress.

Bath & Body Works, Inc. Shares Outstanding

Diluted share count per fiscal year — labels show year-over-year change

FY2021 – FY2025

Bath & Body Works, Inc.'s diluted shares decreased 4.2% YoY in FY2025, indicating shareholder-friendly buybacks.

Understanding Shares Outstanding

Diluted shares outstanding counts every share of Bath & Body Works, Inc. that could exist if all stock options, RSUs, and convertibles were exercised. A shrinking count signals buybacks (returning cash to shareholders by reducing the denominator of EPS). A growing count signals dilution — usually from stock-based compensation, secondary offerings, or stock-funded acquisitions. Routine 1–2% growth is typical at large-cap tech companies that pay employees in equity; sustained growth above 5% warrants a look at the cause.

Unlock Full Analysis

Unlock 10-year interactive charts, all 5 valuation models, and full screener access.